Vaccine Breakthrough Infections with SARS-CoV-2 Variants

Hacisuleyman, Ezgi, Hale, Caryn, Saito, Yuhki, Blachere, Nathalie E., Bergh, Marissa, Conlon, Erin G., Schaefer-Babajew, Dennis J., DaSilva, Justin +7 more·2021·New England Journal of Medicine
DOI 10.1056/nejmoa2105000

Cited by (718)

Items 501–600 of 718

  1. Severe acute respiratory syndrome coronavirus 2
    CABI · 2021 · CABI Compendium
  2. Innovations and challenges in vaccine development: Lessons from the SARS-CoV-2 pandemic and prospects
    Ahmed Mohammed, Nasir A. Ibrahim, Nosiba S. Basher · 2025 · Biochemical and Biophysical Research Communications
  3. The effect of pandemic prevalence on the reported efficacy of SARS-CoV-2 vaccines
    Rajeev Sharma, Abhijith Anand · 2022 · PLoS ONE
  4. Evaluation of the Effectiveness of Immunization Saint-Petersburg Population against COVID-19
    M. G. Daryina, Anna V. Lubimova, Ju. S. Svetlichnaya, Захватова Анастасия Сергеевна, A. V. Jazenok, Харит Сусанна Михайловна, Batyrbek I. Aslanov · 2022 · Epidemiology and Vaccinal Prevention
  5. The Screening of Broadly Neutralizing Antibodies Targeting the SARS-CoV-2 Spike Protein by mRNA Immunization in Mice
    Zhiyin An, Yu Zhang, Xiang Yu, Jia Hui XIA, Yanan Yin, Guoming Li, Jing Lu, Xuemei Fan, Yingjie Xu · 2023 · Pharmaceutics
  6. Incidence of breakthrough infections after COVID-19 vaccination among the COVID-19 vaccine recipients at a Tertiary Care Hospital in Srinagar
    Syed Najmul Ain, Anjum Bashir Fazili, Rohul Jabeen Shah, FerheenNazir Raja, Deeba Farhat, Isra Nazir · 2023 · Indian Journal of Public Health
  7. Breakthrough COVID-19 infections – Analyzing our experience
    Aneela N. Hussain, Samreen Sarfaraz, Sabiha Anis, Quratulain Shaikh, Anum Rahim, Shameem Behram Khan, Rabeea Shah, Owais Khan · 2023 · Pakistan Journal of Medical Sciences
  8. A Mechanical Assay for the Quantification of Anti-RBD IgG Levels in Finger-Prick Whole Blood
    Yu Zhou, Xiaodan Zhao, Yanqige Jiang, Dennis J. X. Lin, Lu Chen, Yinan Wang, Shimin Le, Rong Li, Jie Yan · 2023 · ACS Sensors
  9. Clinical Features and Outcomes of Hospitalized Adult Patients With Breakthrough COVID-19 Infections: A Propensity-Score–Matched Observational Study
    Jianli Niu, Shenae K. Samuels, Candice Sareli, Daniel Mayer, Alvaro Visbal, Aharon E. Sareli · 2023 · American Journal of Epidemiology
  10. Shift in Demographic Involvement and Clinical Characteristics of COVID-19 From Wild-Type SARS-CoV-2 to the Delta Variant in the Indian Population: In Silico Analysis
    Ashutosh Kumar, Adil Asghar, Khursheed Raza, Ravi Kant Narayan, Rakesh K Jha, Abhigyan Satyam, Gopichand Kumar, Prakhar Dwivedi, Chetan Sahni, Chiman Kumari et al. · 2024 · Interactive Journal of Medical Research
  11. A systems biology approach unveils different gene expression control mechanisms governing the immune response genetic program in peripheral blood mononuclear cells exposed to SARS-CoV-2
    Damariz Marin, Geysson Javier Fernández, Juan Carlos Hernández, Natalia A. Taborda · 2024 · PLoS ONE
  12. Amitriptyline potently neutralizes distinct SARS-CoV-2 variants including D614G, Omicron BA.5, and Omicron XBB.1
    Isabel Zydek, Laura Thümmler, Nadine Beckmann, Carolin Sehl, Matthias Soddemann, Rabea Grüneberg, Carina Elsner, Markus Kamler, Ulf Dittmer, Oliver Witzke et al. · 2025 · Frontiers in Microbiology
  13. Novel Assays for Molecular Detection of Severe Acute Respiratory Syndrome Coronavirus 2
    Kyle G. Rodino, Kenneth P. Smith, Matthew Aaron Pettengill · 2022 · Clinics in Laboratory Medicine
  14. Description of Symptoms Caused by the Infection of the SARS-CoV-2 B.1.621 (Mu) Variant in Patients With Complete CoronaVac Vaccination Scheme: First Case Report From Santiago of Chile
    Carlos Barrera‐Avalos, Roberto Luraschi, Claudio Acuña‐Castillo, Mabel Vidal, Andrea Mella‐Torres, Ailén Inostroza-Molina, Rodrigo Vera, Sergio Vargas, Iván Hernández, Christian Perez et al. · 2022 · Frontiers in Public Health
  15. Nomogram Model for Prediction of SARS-CoV-2 Breakthrough Infection in Fujian: A Case–Control Real-World Study
    Tianbin Chen, Yongbin Zeng, Di Yang, Wenjing Ye, Jiawei Zhang, Caorui Lin, Yihao Huang, Yucheng Ye, Jianwen Li, Qishui Ou et al. · 2022 · Frontiers in Cellular and Infection Microbiology
  16. Management of patients with SARS-CoV-2 infections with focus on patients with chronic lung diseases (as of 10 January 2022)
    Horst Olschewski, Ernst Eber, Brigitte Bucher, Klaus Hackner, Sabin Handzhiev, Konrad Höetzenecker, Marco Idzko, Walter Klepetko, Gábor Kovács, Bernd Lamprecht et al. · 2022 · Wiener klinische Wochenschrift
  17. Integrated Surveillance System for Controlling COVID-19 on a University Campus, 2020‒2021
    Genevive R. Meredith, Marwan Osman, Casey L. Cazer, Kevin J. Cummings, Jason D. Hecht, Cecelia G. Madsen, Laura Beth Santacrose, Abigail Seo-Youn Dubovi, Marin E. Clarkberg, Tyler Johnson et al. · 2022 · American Journal of Public Health
  18. Fifteen-Month Follow-Up of Anti-Spike Receptor-Binding Domain SARS-CoV-2 Antibodies among Healthcare Workers in Boston, MA
    Maura C Dodge, Manisha Cole, Elizabeth R. Duffy, Martha M. Werler, Yachana Kataria · 2022 · The Journal of Applied Laboratory Medicine
  19. The genomic and clinical features of the COVID-19 Omicron variant: a narrative review
    Decsa Medika Hertanto, Henry Sutanto, Maria Inge Lusida, Kuntaman Kuntaman, Djoko Santoso · 2022 · F1000Research
  20. Comparison of the duration of viral RNA shedding and anti-SARS-CoV-2 spike IgG and IgM antibody titers in COVID-19 patients who were vaccinated with inactivated vaccines or not: a retrospective study
    Chuancai Xu, Zhisong He, Wei Lei, Li Chen, Dan Shen, Xiaofei Wang, Deyu Xu, Ying Ming Xu, Jianan Huang · 2022 · BMC Infectious Diseases
  21. Serologic Response and Safety after a Third Dose of the COVID-19 BNT162b2 Vaccine in Patients with Inflammatory Bowel Diseases
    Hadar Edelman-Klapper, Keren Masha Rabinowitz, Eran Zittan, Ariella Bar‐Gil Shitrit, Idan Goren, Irit Avni‐Biron, Jacob E. Ollech, Lev Lichtenstein, Hagar Banai-Eran, Henit A. Yanai et al. · 2023 · Vaccines
  22. Immunological changes in a cohort of COVID-19 survivors: Mansoura University experience
    Tamer Ali Elhadidy, Heba Wagih Abdelwahab, Doaa Abdelhalim Shahin, Asem A. Hewidy, Eman Omar Khashaba, Rehab Ahmad Elmorsey, Nermin Abo El Kheir, Elsayed A. Eid, Ahmed El‐Mesery, Marwa O. Elmaria · 2023 · F1000Research
  23. Acceptance of Annual Booster Doses of COVID-19 Vaccines Among Indian Healthcare Professionals: A Pan-India Cross-Sectional Survey
    Ekta Krishna, Venkatesh Karthikeyan, Shamshad Ahmad, Alok Ranjan, Abul Hasan KM, Sanjay Pandey, Pragya Kumar, Chandramani Singh · 2023 · Cureus
  24. Die Corona-Pandemie und Multiple Sklerose: Impfungen und deren Implikationen für Patienten – Teil 2: Impfstofftechnologien
    Tobias Monschein, Tobias Zrzavy, Micha Löbermann, Alexander Winkelmann, Thomas Berger, Paulus Stefan Rommer, Hans‐Peter Hartung, Uwe Klaus Zettl · 2021 · Der Nervenarzt
  25. SEPAR recommendations and new challenges on COVID-19 vaccine in respiratory diseases
    David de la Rosa, José Luís López-Campos, Marina Blanco‐Aparicio, Felipe Villar Álvarez · 2021 · Vacunas (English Edition)
  26. COVID-19 Infection in Vaccinated Healthcare Professionals
    Muneeb Ullah, Muaz Mubashir, Hassan Atique, Farhan Aslam, Musfirah Tahir, Mehdi Naqvi · 2022 · Cureus
  27. CovRadar: Continuously tracking and filtering SARS-CoV-2 mutations for molecular surveillance
    Alice Wittig, Fábio Malcher Miranda, Martin Hölzer, Tom Altenburg, Jakub M. Bartoszewicz, Sebastian Beyvers, Marius Alfred Dieckmann, Ulrich Genske, Sven H. Giese, Melania Nowicka et al. · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
  28. Impact of BNT162b first vaccination on the immune transcriptome of elderly patients infected with the B.1.351 SARS-CoV-2 variant
    Ludwig Knabl, Hye‐Kyung Lee, Manuel Wieser, Anna Mur, August Felix Zabernigg, Ludwig Knabl, Simon Rauch, Matthias Böck, Jana Schumacher, Norbert Kaiser et al. · 2021 · medRxiv
  29. Community-Based Phenotypic Study of Safety, Tolerability, Reactogenicity and Immunogenicity of Emergency-Use-Authorized Vaccines Against COVID-19 and Viral Shedding Potential of Post-Vaccination Infections: Protocol for an Ambispective study
    Irene S. Gabashvili · 2021 · medRxiv
  30. Breakthrough SARS-CoV-2 infections in an eastern state of India: A preliminary report
    Girish Chandra Dash, Subhra Subhadra, Jyotirmayee Turuk, Debaprasad Parai, Sonalika Rath, Jyotsamayee Sabat, Usha Kiran Rout, Srikanta Kanungo, Hari Ram Choudhary, Rashmi Ranjan Nanda et al. · 2021 · Research Square
  31. Post-Vaccination Symptomatic SARS-CoV-2 Infections are Minimal and Non-Serious: An Observational Multicenter Indian Cohort Study of 28342 Healthcare Workers
    Raju Vaishya, Anupam Sibal, Arpita Malani, Sujoy Kar, Hari Prasad K, Kiran SV, Sangita Reddy, Shobana Kamineni, Suneeta Reddy, P Amulya Reddy et al. · 2021 · SSRN Electronic Journal
  32. Gramicidin S and Melittin - Potential anti-viral therapeutic peptides to treat SARS-CoV-2 infection
    Mohammed Ghalib, Yash Parekh, Sarena Banu, Sushma Ram, Ramakrishnan Nagaraj, Bokara Kiran Kumar, Mohammed M. Idris · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
  33. Author response: Cross-reactive antibodies after SARS-CoV-2 infection and vaccination
    Marloes Grobben, Karlijn van der Straten, Philip J. M. Brouwer, Mitch Brinkkemper, Pauline Maisonnasse, Nathalie Dereuddre‐Bosquet, Brent Appelman, AH Ayesha Lavell, Lonneke A. van Vught, Judith A. Burger et al. · 2021 · eLife
  34. Real Concerns over COVID-19 Variants of Concern
    Hatem Hatem, Rashika El Ridi · 2021
  35. In Vitro Inhibition of SARS-CoV-2 Infection by Dry Algae Powders
    Daniel García-Ruíz, Erendira Villalobos-Sánchez, David Alam-Escamilla, Darwin Elizondo‐Quiroga · 2022 · Research Square
  36. An Ultrapotent Neutralizing Bispecific Antibody with Broad Spectrum Against SARS-CoV-2 Variants
    Hui Zhang, Haohui Huang, Rong Li, Lu Zhang, Zhiwei Wang, Jiaping Li, Junyou Chen, Huafei Su, Dandan Zheng, Ziqi Su et al. · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
  37. Pseudotyped Viruses for Coronaviruses
    Meiyu Wang, Jianhui Nie, Youchun Wang · 2023 · Advances in experimental medicine and biology
  38. The dynamics of SARS-CoV-2 infection in unvaccinated and vaccinated populations in Mumbai, India, between 28 December 2020 and 30 August 2021
    Venkanna Bhanothu, Kiran Munne, Shailesh Shankar Pande, Priyanka Singh, Dhanashree D. Jagtap, Clara C. Aranha, Dimpu Gogoi, Sharad Bhagat, Reshma Gaonkar, Shilpa Chandrakant Kerkar et al. · 2023 · Archives of Virology
  39. COVID-19 and the Heart: Lessons Learned and Future Research Directions
    Tetz C. Lee, Alaa Mabrouk Salem Omar, Jonathan N. Bella · 2024 · Cardiogenetics
  40. A colorimetric reverse transcription-loop mediated isothermal amplification (RT-LAMP) method for the rapid detection of SARS-CoV-2 in Thailand
    Payu Bhakdeenuan · 2024 · Tropical biomedicine
  41. Long Term Follow Up of Antibody Titres Against SARS-CoV-2 6 Months After Primary Protein Subunit COVID-19 Vaccination (ZF2001) in Indonesian Adults and Older Adults
    Rodman Tarigan Girsang, Eddy Fadlyana, Kusnandi Rusmil, Muhammad Gilang Dwi Putra, Rona Kania Utami, Alvira Dwilestarie Putri, Hadyana Sukandar · 2024 · Open Access Journal of Clinical Trials
  42. Monoclonal antibodies: their place in applied medicine and their role in the newest infectious disease – history, present, and future. Literature review
    Petar Yordanov Atanasov, Maria Georgieva Moneva-Sakelarieva, Yozlem Ali Kobakova, Stefka Achkova Ivanova, Maria Stamova Vakrilova Becheva, Angelina Georgieva Kirkova-Bogdanova, Maria Sevdelinova Chaneva, Ventseslava Petrova Atanasova, Radoslav Fedeev Todorov, Nikolay Zarkov Bashev et al. · 2025 · Pharmacia
  43. Six-month follow-up of antibody response to bivalent mRNA SARS-CoV-2 vaccine booster in healthcare workers
    Giorgio Fedele, Ilaria Schiavoni, Filippo Trentini, Pasqualina Leone, Eleonora Olivetta, Stefano Fiore, Angela Di Martino, Sergio Abrignani, Alessandra Bandera, Pierangelo Clerici et al. · 2025 · Vaccine
  44. Predicting the trend of SARS-CoV-2 mutation frequencies using historical data
    Xinyu Zhou, Yi Yan, Kevin Hu, Hai-Xu Tang, Yi-Jie Wang, Lu Wang, Chi Zhang, Sha Cao · 2025 · Bioinform.
  45. Pandemic vaccines and ‘The Global Public Good’: a call for distributive justice
    Norman Kenneth Swazo, Md. Munir Hossain Talukder, Mohammad Kamrul Ahsan · 2025 · Medicine Health Care and Philosophy
  46. Combination mRNA Vaccine Adjuvanted with CpG Oligodeoxynucleotides Enhances Protection against Respiratory Virus Infection
    Lingyan Cui, Sibo Zhang, Yarong Zeng, Limin Zhang, Min Lin, Minqing Hong, Huiqing Chen, Hong Wang, Wenhui Xue, Miaolin Lan et al. · 2026 · ACS Nano
  47. The Increased Burden of SARS-CoV-2 Infection in Orthopaedic Trauma Patients: Comparison of Demographics of Both the Waves of the Pandemic—An Indian Tertiary Center Experience
    Sandeep Patel, Shahnawaz Khan, Sameer Aggarwal, Vishal Kumar, Siddhartha Sharma, Mandeep Singh Dhillon · 2021 · Indian Journal of Orthopaedics
  48. Developing COVID-19 vaccine policy in increments
    Michael S. Saag · 2021 · The Lancet
  49. Demographic Features of COVID-19 in Two Waves in A Single Center
    Rishav Mukherjee, Dharitri CHAUDHURİ, Arup Kumar Mitra, Partha GUCHHAİT, Subhrojyoti BHOWMİK, Satadal Das, Bhaskar Narayan Chaudhuri · 2021 · Journal of Microbiology and Infectious Diseases
  50. Genomic Analysis of AZD1222 (ChAdOx1) Vaccine Breakthrough Infections in the City of Mumbai
    Arusha Shetty, Gaurav Chatterjee, Sweta Rajpal, Tuhina Srivastava, Nilesh Gardi, Sumeet Prakash Mirgh, Anant Ganesh Gokarn, Sachin B. Punatar, Nitin Shetty, Amit D. Joshi et al. · 2022 · International Journal of Clinical Practice
  51. Clinical and Laboratory Features in the Israeli Population with COVID-19 Infection after Pfizer-BioNTech mRNA Booster Vaccination
    Ariel Israel, Eugene Merzon, Yotam Shenhar, Ilan Green, Avivit Golan‐Cohen, Alejandro A. Schäffer, Eytan Ruppin, Shlomo Vinker, Eli Magen · 2022 · Vaccines
  52. Molnupiravir for treating COVID-19
    Eleanor Ochodo, Eddy Johnson Owino, Bruce Nyagol, Tilly Fox, Michael McCaul, Tamara Kredo, Karen Cohen, Priscilla Rupali · 2022 · Cochrane Database of Systematic Reviews
  53. Molecular Epidemiology of SARS-CoV-2 in Healthcare Workers and Identification of Viral Genomic Correlates of Transmissibility and Vaccine Break Through Infection: A Retrospective Observational Study From a Cancer Hospital in Eastern India
    Sanjay Bhattacharya, Soumyadip Chatterji, Mammen Chandy, Aseem Yogishwar Mahajan, Gaurav Goel, Deepak Mishra, Priyanka Vivek, Parijat Das, Sudipto Mandal, Anup N. Chugani et al. · 2021 · Indian Journal of Medical Microbiology
  54. Durability of antibodies post vaccination with two doses of inactivated BBIBP-CorV vaccine
    Sally Mahmoud, Subhashini Ganesan, Narjes Saheb Sharif‐Askari, Flavia Martinez Cantarutti, Hannah V. Wilson, Pauline Ogrodzki, Rabih Halwani, Nawal Al Kaabi, Walid Abbas Zaher · 2022 · Current Medical Research and Opinion
  55. The “vaccine” hubbub: Viral load comparisons of SARS‐CoV‐2 Delta and Omicron variants against different vaccine–booster vaccine combinations
    Mahmut Çerkez Ergören, Gökçe Akan, Ender Volkan, Emine Kandemiş, Emine Ünal Evren, Hakan Evren, Eliz Volkan, Gülten Tuncel, Kaya Süer, Tamer Şanlıdağ · 2022 · Journal of Medical Virology
  56. A Study to Assess Symptom Profile and Break Through Infections Among Health Care Workers Post Covid Vaccination at Tertiary Care Health Facility
    Vishal Malhotra, Simmi Oberoi, Ravinder Khaira, Rajinder Singh Balgir, Balpreet Kaur, Sakshi Kaura · 2022 · Indian Journal of Community Medicine
  57. Vaccinated Healthcare Workers’ Adherence to COVID-19 Prevention Measures and Associated Factors in Northwest Ethiopia: A Facility-Based Cross-Sectional Study
    Kale Gubae, Samuel Agegnew Wondm, Worku Birhane, Akalu Fetene Desalew, Tilaye Arega Moges, Mekdes Kiflu · 2022 · Risk Management and Healthcare Policy
  58. Propagation of SARS-CoV-2 in a Closed Cell Culture Device: Potential GMP Compatible Production Platform for Live-Attenuated Vaccine Candidates under BSL-3 Conditions?
    Stephan Klessing, Antonia Sophia Peter, Kirsten Fraedrich, Jannik T. Wagner, Mirko Kummer, Janina Deutschmann, Philipp A. Steininger, Hans-Dieter Steibl, Klaus Überla · 2023 · Viruses
  59. Molecular determinants associated with temporal succession of SARS-CoV-2 variants in Uttar Pradesh, India
    Smita Pal, Poonam Mehta, Ankita Pandey, Anam Ara, Ujjala Ghoshal, Uday C. Ghoshal, Rajesh Pandey, Raj Kamal Tripathi, Prem Narayan Yadav, Ravishankar Ramachandran et al. · 2023 · Frontiers in Microbiology
  60. "Sinopharm", "Oxford-AstraZeneca", and "Pfizer-BioNTech" COVID-19 vaccinations: testing efficacy using lung CT-volumetry with comparative analysis of variance (ANOVA)
    Ahmed Samir, Dina Abdel Salam Altarawy, Rania Ahmed Sweed, Amr Abdel-Kerim · 2023 · The Egyptian Journal of Radiology and Nuclear Medicine
  61. Advances in Diagnosis and Treatment for SARS-CoV-2 Variants
    Naheed Akhter, Sadia Sana, Muhammad Adnan Ahsan, Zafaar Siddique, Abu Huraira, Somara Sana · 2023 · Infectious diseases
  62. A systematic review on Drug Re-profiling/Re-Purposing
    Bharti Sharma, Dinesh Kumar Yadav · 2022 · IARS International Research Journal
  63. Sequencing the SARS-CoV-2 Genome from Stool Samples of Post-acute Cases Implicates a Novel Mutation Associated with Reduced Antibody Neutralization
    Nataliya Panova, Nina P. Allan, Noelle C. Rubas, Rosa H. Lee, Braden P. Kunihiro, Lesley Umeda, Rafael Peres, Rubén Juárez, Alika K. Maunakea · 2023 · European Journal of Biomedical Research
  64. A Novel Multi-epitope Vaccine Against SARS-CoV-2 Variants of Concern Strains Applying Immunoinformatics Approaches
    Samaneh Jahandar-Lashaki, Safar Farajnia, Morteza Milani, Mohammad Kazem Hosseini, Rana Yousefzadeh · 2023 · ImmunoAnalysis
  65. Breakthrough infection among healthcare personnel following exposure to COVID-19: Experience after one year of the world’s largest vaccination drive
    Arghya Das, Salman Khan, Ashima Jain Vidyarthi, Raghav Gupta, Saikat Mondal, Sheetal Singh, LaxmiTej Wundavalli, Sushma Bhatnagar, Urvashi Balbir Singh, Rama Chaudhry · 2023 · Journal of Family Medicine and Primary Care
  66. Clinical characteristics, outcomes, and risk factors of SARS-CoV-2 breakthrough infections among 572 fully vaccinated (BBIBP-CorV) hospitalized patients
    Yihuang Liu, Peilin Liu, Yuming Sun, Guangtong Deng · 2023 · Heliyon
  67. Mutation Interest in the Receptor-Binding Domain of Spike Protein of Severe Acute Respiratory Syndrome Coronavirus 2 in the Northwest of Iran
    Chiman Karami, Vahid Asghariazar, Yasamin Pahlavan, Kamyar Mazloum Jalali, Ahmad Tajehmiri, Mohammad GhorbaniVanan, Elham Safarzadeh · 2023 · Jundishapur Journal of Microbiology
  68. COVID-19 Vaccine hesitancy and influencing factors: An example from Turkey
    Didem Sarımehmet, Yakup Kadri SARIMEHMET, Bahar Candaş Altınbaş, Cüneyt ARDIÇ · 2024 · Pakistan Journal of Medical Sciences
  69. Impact of COVID-19 on patients undergoing scheduled procedures for chronic venous disease
    Ethan T. Moore, Max Valentin Wohlauer, James Dorosh, Mahmood S. Kabeil, Rafael Demarchi Malgor, Leigh Ann O’Banion, Gabriel López-Peña, Riley A. Gillette, Kathryn L. Colborn, Robert F. Cuff et al. · 2024 · Vascular
  70. SARS-CoV-2 variant replacement constrains vaccine-specific viral diversification
    Bethany L. Dearlove, Anthony C Fries, Nusrat J Epsi, Stephanie A Richard, Anuradha Ganesan, Nikhil Huprikar, David A Lindholm, Katrin Mende, Rhonda E Colombo, Christopher J. Colombo et al. · 2024 · Virus Evolution
  71. Stochastic network to model the global spreading of respiratory diseases: From SARS-CoV-2 to pathogen X pandemic
    Leonardo López, Xavier Rodó · 2024 · Ecological Informatics
  72. The type of the first prime/boost vaccine against SARS-CoV-2 exerts long-term effects on the humoral immune response
    Franz Mai, Emil Christian Reisinger, Brigitte Müller‐Hilke · 2025 · Clinical Immunology
  73. COVID-19 Infection, Drugs, and Liver Injury
    Dianya Qiu, Weihua Cao, Yaqin Zhang, Hongxiao Hao, Xin Chuan Wei, Linmei Yao, Shuojie Wang, Zixuan Gao, Yao Xie, Minghui Li · 2025 · Journal of Clinical Medicine
  74. COVID-19 vaccination and public health measures
    Gentle Sunder Shrestha, Sabin Bhandari · 2021 · Nepal Mediciti Medical Journal
  75. SARS-CoV-2 Variants: Surveillance, Evaluation, and Challenges
    Baoying Huang, Wenjie Tan · 2021 · Infectious Diseases & Immunity
  76. Breakthrough infection after Covishield COVID-19 vaccine among health care workers at Patan Academy of Health Sciences, Nepal
    Jay Narayan Shah, Priscilla Samson, Nabees Man Singh Pradhan, Ashis Shrestha, Shreekrishna Maharjan, Shanta Dangol Shrestha, Sarala KC · 2021 · Journal of Patan Academy of Health Sciences
  77. Single Center Study of Vaccination Breakthrough infection with SARS-CoV-2 Among Erbil Population in August 2021
    Zakarea Abdullah Yaseen Al-khayat, Sharmeen Qadr Faqi, Dlshad Abdullah Hasan, Dalia Yaqoub Falo · 2021 · Journal of Contemporary Medical Sciences
  78. Humoral Response after Vaccination with Half-Dose of BNT162b2 in Subjects under 55 Years of Age
    Krzysztof Łukaszuk, Amira Podolak, Grzegorz Jakiel, Jolanta Kiewisz, Izabela Wocławek-Potocka, Aron Łukaszuk, Łukasz Rąbalski · 2021 · Vaccines
  79. Environmental sampling of the severe acute respiratory syndrome coronavirus 2 Delta variant in the inpatient wards of a hospital in Nanjing
    Ming Chu, Minjuan Chu, Yiping Mao, Zhanjie Li, Shuangyuan Liu, Hui Liu, Jingwu Ge, Zhihang Peng, Yang Yongfeng, Yun Liu et al. · 2021 · Annals of Translational Medicine
  80. Ad26.COV2.S boosts antibody and T-cell responses following BNT162b2 vaccination
    Sho Iketani, Lihong Liu, Manoj S. Nair, Abishek Chandrashekar, Hiroshi Mohri, Maple Wang, Dan H. Barouch, Yaoxing Huang, David D. Ho · 2021 · Emerging Microbes & Infections
  81. Outsmarting the Virus
    John Hewitt · 2021 · Inference International Review of Science
  82. COVID-19, the Pandemic, and Challenges Associated with Vaccines
    Lidong Wang · 2021 · Open Access Journal of Biogeneric Science and Research
  83. Clinico-Demographic Profile of Vaccinated/Partially Vaccinated Versus Non-Vaccinated Covid-19 Cases in Second Wave of India
    Piyush Arora, Neeraj Gupta, Deepti Rathee, Jose K. Jimmy · 2022 · Journal of Evolution of Medical and Dental Sciences
  84. Impact of vaccination on SARS-CoV-2 infection
    Nupur Pal, Debalina Nag, Jayeeta Halder, Aritra Biswas, Raja Ray, Avijit Hazra, Chitrita Chatterjee · 2022 · Asian Pacific Journal of Tropical Medicine
  85. The genomic and clinical features of the COVID-19 Omicron variant: a narrative review
    Decsa Medika Hertanto, Henry Sutanto, Maria Inge Lusida, Kuntaman Kuntaman, Djoko Santoso · 2022 · F1000Research
  86. Risk Stratification of SARS-CoV-2 Breakthrough Infections Based on an Outbreak at a Student Festive Event
    Ralph Bertram, Vanessa Bartsch, Johanna Sodmann, Luca Hennig, Engin Müjde, Jonathan Stock, Vivienne Ruedig, Philipp Sodmann, Daniel Tödt, Eike Steinmann et al. · 2022 · Vaccines
  87. Systematic Literature Review: Could Plasma Convalescent Prevent Death on COVID-19?
    Jordan Steven Widjaja, Prawesty Diah Utami, Jeanaya Hedya Alfara Putri, Yemima Billyana Kusbijantoro · 2021 · JURNAL PENDIDIKAN KEPERAWATAN INDONESIA
  88. In silico Identification of a Viral Surface Glycoprotein Site Suitable for the Development of Low Molecular Weight Inhibitors for Various Variants of the SARS-CoV-2
    Andrii A. Zaremba, Polina Yu. Zaremba, F.V. Muchnyk, G.V. Baranova, Svіtlana Zahorodnia · 2021 · Mikrobiolohichnyi Zhurnal
  89. Perspective Chapter: Emerging SARS-CoV-2 Variants of Concern (VOCs) and Their Impact on Transmission Rate, Disease Severity and Breakthrough Infections
    Arbind Kumar, Aashish Sharma, Narendra Vijay Tirpude, Yogendra Shantaram Padwad, Shaifali Sharma, Sanjay Kumar · 2022 · Infectious diseases
  90. Epidemiological Analysis of COVID-19 Outbreaks in Wuhu, China, from January to March 2020
    Nicole Liu, Minmin Xiao, Jinhong Zhao, Shuzhi Zhong, Ximei Wang, Lina Nie, Yanni Ma, Yujun Liu, Zhu Yang · 2022 · Jundishapur Journal of Microbiology
  91. Observation on the R&D Effectiveness and Application of China's Novel Coronavirus Vaccine
    Xiang Yu, Na Li, Hui Wang · 2023 · Biotechnology Law Report
  92. Anti‐SARS‐CoV‐2 spike immunoglobulin G and immunoglobulin M titers decline as interval from the second inactivated vaccine dose to the onset of illness is prolonged in breakthrough infection patients
    Chuancai Xu, Zhisong He, Wei Lei, Jinzhou Zhu, Da‐guo Zhao, Jindan Kong, Wei Yao, Ying Ming Xu, Jianan Huang · 2023 · The Clinical Respiratory Journal
  93. Extraction Bottleneck in the Diagnosis of SARS-CoV-2: Evaluation of an Alternative Protocol Derived from Veterinary Use
    Paolo Bottino, Elisa Zanotto, Francesca Sidoti, Lisa Pastrone, Roberto Piva, Elisabetta Mereu, Cristina S. Costa, Rossana Cavallo · 2023 · Microorganisms
  94. Coronavirus disease 2019 in the occupational settings
    Maria Grazia Lourdes Monaco, Gianluca Spiteri, Stefano Porru · 2022 · Current Opinion in Epidemiology and Public Health
  95. KEJADIAN INFEKSI PASCA VAKSINASI COVID-19 DOSIS PRIMER PADA SASARAN VAKSIN LANJUTAN DI SENTRA VAKSINASI COVID-19 UNIVERSITAS TARUMANAGARA
    Wiyarni Pambudi, Sari Mariyati Dewi Nataprawira, Andria Priyatna, Yoanita Widjaja, Jennefer, Sannya Christy · 2022 · Jurnal Muara Medika dan Psikologi Klinis
  96. A study to assess the severity and risk of COVID-19 breakthrough infection in admitted SARS-CoV-2 vaccinated individual
    Shital Dhoble, Devishri Atram, Niwrutti N. Jiwane, Anil Naitam · 2023 · Journal of Family Medicine and Primary Care
  97. Association between pregnancy and severe COVID-19 symptoms in Qatar: A cross-sectional study
    Alla’ K. Al-Qassem, Ammar B. Humaidi, Amna K. Al-Kuwari, Elham M. Hasan, Nosaiba H. Yakti, Rakan M. Al-Hathal, Devendra Bansal, Elmoubasher Farag, Hamad Eid Al‐Romaihi, Mohammed Al‐Thani et al. · 2023 · PLOS Global Public Health
  98. Detection of a SARS-CoV-2 P.1.1 variant lacking N501Y in a vaccinated health care worker in Italy
    Silvia Angeletti, Marta Giovanetti, Marta Fogolari, Lucia De Florio, Maria Angela Francesconi, Roberta Veralli, Francesca Antonelli, Daniele Donati, Ginevra Azzurra Miccoli, Vagner Fonseca et al. · 2021 · Journal of Infection
  99. Serial evaluation of anti-SARS-CoV-2 IgG antibody and breakthrough infections in BNT162b2 Vaccinated migrant workers from Bangladesh
    Ashraful M. Hoque, M M Rahman, Anindita Das · 2021 · medRxiv
  100. Systems immune profiling of variant-specific vaccination against SARS-CoV-2
    Lei Peng, Jonathan Joon-Young Park, Zhenhao Fang, Xiaoyu Zhou, Matthew B. Dong, Qiancheng Xiong, Chenxiang Lin, Sidi Chen · 2021 · bioRxiv (Cold Spring Harbor Laboratory)